Viking Therapeutics, Inc.

Ownership Transactions Reported by 8 Insiders

Symbol
VKTX on Nasdaq
Location
9920 Pacific Heights Blvd, Suite 350, San Diego, CA

Insiders trading volume in the past year

Viking Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Brian Lian President & CEO, Director $355M -$41M -10.4% Sep 20, 2024
Marianna Mancini Chief Operating Officer $48.8M -$23.2M -32.2% Jul 29, 2024
Greg Zante Chief Financial Officer $24.3M -$6.18M -20.3% Jul 29, 2024
Lawson Macartney Director $1.11M Jan 2, 2024
Charles A. Rowland Jr Director $692K Jan 2, 2024
J. Matthew Singleton Director $660K -$3.3M -83.3% Sep 20, 2024
Sarah Kathryn Rouan Director $0 -$1.39M -100% Feb 8, 2024
Matthew W. Foehr Director Jan 2, 2024

Recent Insider Transactions by Companies or Individuals for Viking Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.